Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative approach to blood screening using the ExaVir reverse transcriptase activity assay.

Elizabeth Seyoum1, Dawit Wolday, Teferi Mekonen

  • 1Ethio-Netherlands AIDS Research Project (ENARP), Ethiopian Health and Nutrition Research Institute (EHNRI), Addis Ababa.

Current HIV Research
|October 28, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Findings from comprehensive genome sequencing in the Canadian population: Results from the GENCOV Study.

Genetics in medicine open·2026
Same author

High-risk human papillomavirus positivity and associated factors among women living with HIV in public health facilities of Mekelle, Northern Ethiopia.

Infectious agents and cancer·2026
Same author

Project ODIN: advancing environmental genomic surveillance for public health across sub-Saharan Africa.

The Lancet. Microbe·2026
Same author

Reverse transcriptase mediated signal amplification in ligand binding assays.

SLAS technology·2026
Same author

High-risk human papillomavirus and HBV, HCV, and T. pallidum association among women living with HIV in selected health facilities of Mekelle, Tigray, Northern Ethiopia.

Scientific reports·2026
Same author

Trends, magnitude and determinants of viral load suppression among HIV patients on highly active anti-retroviral therapy in Tigray region, Ethiopia: a retrospective study (2016-2024).

BMC infectious diseases·2026

This study evaluated HIV screening tests in Ethiopia, finding a 3.4% prevalence. An ExaVir Load test detecting HIV reverse transcriptase (RT) showed promise for blood screening alongside conventional methods.

Area of Science:

  • Virology
  • Public Health
  • Medical Diagnostics

Background:

  • Blood transfusion safety is critical for public health.
  • Accurate and sensitive human immunodeficiency virus (HIV) screening is essential to prevent transmission.

Purpose of the Study:

  • To compare the performance of HIV screening tests, including a novel reverse transcriptase (RT) assay, in an Ethiopian blood donor population.
  • To assess the utility of detecting HIV reverse transcriptase (RT) activity as an additional marker for blood screening.

Main Methods:

  • Screening of 408 blood samples using Vironostika Ag/Ab assay, Amplicor DNA PCR, and ExaVir Load test (colorimetric and fluorimetric versions).
  • Supplementary testing was employed to resolve discordant results and confirm HIV status.
  • Evaluation of HIV prevalence and test performance characteristics (sensitivity, specificity, false positives/negatives).

Related Experiment Videos

Main Results:

  • An HIV prevalence of 3.4% (14/408) was identified.
  • Vironostika Ag/Ab test yielded 14 true positives and 3 false positives.
  • Amplicor DNA PCR produced 14 true positives, 2 probable false positives, and 8 indeterminate results.
  • The colorimetric ExaVir Load test demonstrated 100% specificity but missed one low-viral-load sample, which was detected by the fluorimetric version.

Conclusions:

  • The ExaVir Load test, particularly the fluorimetric version, shows potential for HIV blood screening by detecting RT activity.
  • Integrating RT detection could enhance the sensitivity and safety of blood transfusion services.
  • Further validation of RT-based assays in diverse populations is warranted.